birch beer
Selected indexed studies
- Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical Trial. (JAMA, 2025) [PMID:40388916]
- Dexamethasone in Hospitalized Patients with Covid-19. (N Engl J Med, 2021) [PMID:32678530]
- Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial. (Lancet, 2025) [PMID:40897189]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Dexamethasone in Hospitalized Patients with Covid-19. (2021) pubmed
- Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial. (2025) pubmed
- Critical care unit bed availability and postoperative outcomes: a multinational cohort study. (2024) pubmed
- Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. (2022) pubmed
- GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. (2023) pubmed
- A second update on mapping the human genetic architecture of COVID-19. (2023) pubmed
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. (2021) pubmed
- Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials. (2025) pubmed
- Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical Trial. (2025) pubmed
- Simvastatin in Critically Ill Patients with Covid-19. (2023) pubmed